Treatment of angiostrongyliasis
- 1 October 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 102 (10) , 990-996
- https://doi.org/10.1016/j.trstmh.2008.04.021
Abstract
Angiostrongyliasis, caused by Angiostrongylus cantonensis, is endemic in northeastern Thailand and southern and eastern Taiwan and is also reported throughout the world. Humans get infected by eating raw freshwater snails or other paratenic hosts. The three main clinical forms of angiostrongyliasis are: eosinophilic meningitis (EoM), eosinophilic encephalitis (EoE) and ocular angiostrongyliasis. EoM, the most common form, causes acute severe headache, and corticosteroid is the cornerstone treatment. EoE is rare but fatal and has no effective treatment. The clinical presentations are coma and cerebrospinal fluid eosinophils without any other causes of the deterioration of consciousness, such as infection or metabolic derangements. Ocular angiostrongyliasis is very rare and causes a permanent visual impairment and a wide range of ocular inflammation, depending on the worm's route. It can occur with or without EoM. An identification of a living worm, usually a single worm in any part of an eye, is an important diagnostic clue. The treatment options are surgical removal or laser therapy. Corticosteroids may be necessary in the case of coexistence of EoM or other ocular inflammations such as retinitis or optic neuritis. The visual outcome is poor and depends on the initial visual acuity.Keywords
This publication has 45 references indexed in Scilit:
- Eosinophilic Meningitis in a Returned Traveler From Santo Domingo: Case Report and ReviewJournal of Travel Medicine, 2007
- A souvenir from the Pacific IslandsPractical Neurology, 2007
- Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensisZeitschrift Fur Parasitenkunde-Parasitology Research, 2006
- Association of plasminogen activators and matrix metalloproteinase‐9 proteolytic cascade with blood–CNS barrier damage of angiostrongyliasisInternational Journal of Experimental Pathology, 2006
- Pathological changes in the brains of rabbits experimentally infected with Angiostrongylus cantonensis after albendazole treatment: histopathological and magnetic resonance imaging studiesJournal of Antimicrobial Chemotherapy, 2005
- Combined Treatment with Interleukin-12 and Mebendazole Lessens the Severity of Experimental Eosinophilic Meningitis Caused byAngiostrongylus cantonensisin ICR MiceInfection and Immunity, 2003
- An Outbreak of Eosinophilic Meningitis Caused byAngiostrongylus cantonensisin Travelers Returning from the CaribbeanNew England Journal of Medicine, 2002
- Eosinophilia and intracranial worm recovery in interleukin-5 transgenic and interleukin-5 receptor α chain-knockout mice infected with Angiostrongylus cantonensisZeitschrift Fur Parasitenkunde-Parasitology Research, 1997
- The role of eosinophils in Angiostrongylus cantonensis infectionParasitology Today, 1994
- Effect of 1-TetramisoIe on Angiostrongylus cantonensis Infection in RatsChemotherapy, 1969